Omrix Biopharmaceuticals , Nasdaq: OMRI
Develops biosurgical bleeding control and passive immunotherapy products.
Industry: Health Care
First Day Return: +0.3%
Industry: Health Care
OMRI
Develops biosurgical bleeding control and passive immunotherapy products.
| IPO Data | |
|---|---|
| IPO File Date | 01/18/2006 |
| Offer Price | $10.00 |
| Price Range $15.00 - $17.00 | |
| Offer Shares (mm) | 3.4 |
| Deal Size ($mm) | $34 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 04/20/2006 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $34 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | New York, NY, United States |
| Founded | 1995 |
| Employees at IPO | 150 |
| Website www.omrix.com | |
IPO News for Omrix Biopharmaceuticals
- Medical products maker Omrix prices shares at $10 04/21/06
- Biotech Omrix sets terms 03/24/06
- Biotechnology concern Omrix files for IPO 01/18/06
Omrix Biopharmaceuticals (OMRI) Performance
